S280: B-CELL MALIGNANCIES TREATED WITH TARGETED DRUGS AND SARS-COV-2 INFECTION. A EUROPEAN HEMATOLOGY ASSOCIATION SURVEY (EPICOVIDEHA). (23rd June 2022) - Infante, M. S.; Salmanton-García, J.; Fernandez-Cruz, A.; Marchesi, F.; RÁČIL, Z.; Hanakova, M.; Jaksic, O.; Weinbergerova, B.; Besson, C.; Duarte, R.; Itri, F.; VALKOVIĆ, T.; et al.